Alcon (NYSE: ALC) + shares fell this morning on third-quarter results that missed the consensus forecast.
Shares of ALC dipped 6.9% at $69.82 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%.
The Geneva, Switzerland-based company posted profits of $204 million in the quarter. That equals 41¢ per share on sales of $2.3 billion for the three months ended Sept. 30, 2023. Alcon recorded a 75.9% bottom-line gain on sales growth of 8.4%.
However, Alcon fell shy of Wall Street expectations in the third quarter. Adjusted to exclude one-time items, earnings per share of 66¢ fell 1¢ shy of projections. Sales came in just short of the forecast of $2.35 billion as well.
Alcon’s surgical business grew by 5% in the quarter while vision care sales increased by 13%. Demand for advanced intraocular le…